Difference between revisions of "QIBA Collaborations"
Jump to navigation
Jump to search
m |
|||
| (17 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
QIBA is grateful for the support of our collaborators. | QIBA is grateful for the support of our collaborators. | ||
| − | + | ||
| − | + | *Our society partners help QIBA with the development and implementation of quantitative imaging biomarkers, which are essential to precision medicine and AI tools. | |
| + | *The companies offer conformance testing services to help Profile users achieve high-quality quantitative imaging results. | ||
We work together to provide efficient and validated methods for quantifying biomedical imaging results necessary for optimal patient care, clinical research, and new therapy development. | We work together to provide efficient and validated methods for quantifying biomedical imaging results necessary for optimal patient care, clinical research, and new therapy development. | ||
| Line 10: | Line 11: | ||
| − | :[[Image: | + | :[[Image:Logos-Update-Wiki-31JULY2023.png|800px]] |
| + | ==Collaboration Highlights== | ||
| + | *EARL II Pilot Study - Ongoing study to assess international imaging site conformance to the QIBA FDG-PET/CT Profile -August 2022 | ||
| + | *RadSite Pilot Study - Ongoing study to assess accredited imaging site conformance to the QIBA FDG-PET/CT Profile - August 2022 | ||
| + | |||
| + | *The QIBA PET Amyloid Profile has advanced to Stage 3 (Clinically Feasible), and can be found on the QIBA Profiles page: https://qibawiki.rsna.org/index.php/Profiles | ||
| + | |||
{| style="width:80%" border="1" cellpadding="2" | {| style="width:80%" border="1" cellpadding="2" | ||
| − | ! <font color=green>'''Organization'''</font> | + | !<font color="green">'''Organization'''</font> |
| − | ! <font color=green>'''link'''</font> | + | !<font color="green">'''link'''</font> |
|- | |- | ||
| − | | ''' | + | |'''AIUM - American Institute of Ultrasound in Medicine''' |
| − | | https:// | + | |https://www.aium.org/ |
| + | |- | ||
| + | |'''CaliberMRI''' | ||
| + | |https://qmri.com/ | ||
|- | |- | ||
| − | | ''' | + | |'''EARL, ''Research4Life'', under the umbrella of the European Association of Nuclear Medicine (EANM)''' |
| − | | https://www. | + | |https://www.eanm.org/earl-research4life/ |
|- | |- | ||
| − | | ''' | + | |'''EIBALL - European Imaging Biomarkers Alliance, European Society of Radiology (ESR)''' |
| − | | https:// | + | |https://www.myesr.org/about/organisation/statutory-committees/research-committee |
|- | |- | ||
| − | | ''' | + | |'''EIBIR - European Institute for Biomedical Imaging''' |
| − | | https://www. | + | |https://www.eibir.org/ |
|- | |- | ||
| − | | ''' | + | |'''Invicro''' |
| − | | https:// | + | |https://invicro.com/ |
|- | |- | ||
| − | | ''' | + | |'''ISMRM - International Society for Magnetic Resonance in Medicine''' |
| − | | https:// | + | |https://www.ismrm.org/ |
|- | |- | ||
| − | | '''Japan Quantitative Imaging Biomarker Alliance (J-QIBA)''' | + | |'''Japan Quantitative Imaging Biomarker Alliance (J-QIBA), a part of the Japan Radiological Society''' |
| − | | http://www.radiology.jp/j-qiba/english/index.html | + | |http://www.radiology.jp/j-qiba/english/index.html |
|- | |- | ||
| − | | '''Prevent Cancer Foundation''' | + | |'''Prevent Cancer Foundation''' |
| − | | https://www.preventcancer.org/ | + | |https://www.preventcancer.org/ |
|- | |- | ||
| − | | '''RadSite''' | + | |'''RadSite''' |
| − | | https://radsitequality.com/ | + | |https://radsitequality.com/ |
|- | |- | ||
| − | | '''SNMMI - Society of Nuclear Medicine and Molecular Imaging''' | + | |'''SNMMI - Society of Nuclear Medicine and Molecular Imaging''' |
| − | | http://www.snmmi.org/ | + | |http://www.snmmi.org/ |
|} | |} | ||
==Funding Agency== | ==Funding Agency== | ||
[[Image:NIBIB Acknowledgement.jpg|400px]] | [[Image:NIBIB Acknowledgement.jpg|400px]] | ||
Latest revision as of 15:38, 31 July 2023
Collaborative Efforts
QIBA is grateful for the support of our collaborators.
- Our society partners help QIBA with the development and implementation of quantitative imaging biomarkers, which are essential to precision medicine and AI tools.
- The companies offer conformance testing services to help Profile users achieve high-quality quantitative imaging results.
We work together to provide efficient and validated methods for quantifying biomedical imaging results necessary for optimal patient care, clinical research, and new therapy development.
Collaboration Highlights
- EARL II Pilot Study - Ongoing study to assess international imaging site conformance to the QIBA FDG-PET/CT Profile -August 2022
- RadSite Pilot Study - Ongoing study to assess accredited imaging site conformance to the QIBA FDG-PET/CT Profile - August 2022
- The QIBA PET Amyloid Profile has advanced to Stage 3 (Clinically Feasible), and can be found on the QIBA Profiles page: https://qibawiki.rsna.org/index.php/Profiles
| Organization | link |
|---|---|
| AIUM - American Institute of Ultrasound in Medicine | https://www.aium.org/ |
| CaliberMRI | https://qmri.com/ |
| EARL, Research4Life, under the umbrella of the European Association of Nuclear Medicine (EANM) | https://www.eanm.org/earl-research4life/ |
| EIBALL - European Imaging Biomarkers Alliance, European Society of Radiology (ESR) | https://www.myesr.org/about/organisation/statutory-committees/research-committee |
| EIBIR - European Institute for Biomedical Imaging | https://www.eibir.org/ |
| Invicro | https://invicro.com/ |
| ISMRM - International Society for Magnetic Resonance in Medicine | https://www.ismrm.org/ |
| Japan Quantitative Imaging Biomarker Alliance (J-QIBA), a part of the Japan Radiological Society | http://www.radiology.jp/j-qiba/english/index.html |
| Prevent Cancer Foundation | https://www.preventcancer.org/ |
| RadSite | https://radsitequality.com/ |
| SNMMI - Society of Nuclear Medicine and Molecular Imaging | http://www.snmmi.org/ |
Funding Agency
